Literature DB >> 22256779

Meningitis: is a major cause of disability amongst Papua New Guinea children?

Priya Karthikeyan1, Karthikeyan P Ramalingam.   

Abstract

PURPOSE: This article is intended to focus on the need for the use of rehabilitation services, for children with meningitis in Papua New Guinea, which is one of largest developing country in The Pacific with diverse culture and landscape. Meningitis is the fifth leading disease that results in disability in the country. The first line of treatment is usually antibiotics, administration of vaccination is also recommended. Currently community based rehabilitation workers and Physiotherapist offer the rehabilitation services. There is a need for the other rehabilitation professionals and appropriate education to the CBR workers, caregivers for providing effective Rehabilitation.
METHOD: Articles related to meningitis were recruited through various electronic database such as Ovid SP, MEDLINE, CINHAL, Google Scholar and HINARI and EBSCOhost for full text. The search includes journal articles, editorials, research reports, systematic reviews and books.
RESULTS: The neurological sequelae resulting from meningitis are increasing. There is a need for Hib vaccination to reduce the rate of mortality. Physiotherapists are new professionals that emerged since 2006 and are assisting in reducing the motor and neurological disability.
CONCLUSIONS: A multidisciplinary approach is required to manage the child with meningitis. Adequate knowledge, resources and assistance about the condition among the health professionals, carers and teachers would enable the children to achieve the quality of life.

Entities:  

Mesh:

Year:  2012        PMID: 22256779     DOI: 10.3109/09638288.2011.651190

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  1 in total

Review 1.  Brief overview of meningitis in the Pacific Islands, and implications for public health, clinical, and rehabilitation services: A call to action.

Authors:  Annette Kaspar; Sione Pifeleti
Journal:  J Glob Health       Date:  2021-01-16       Impact factor: 4.413

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.